Current Ratio: A liquidity ratio that measures a company's ability to pay short-term obligations. Calculated as: Total Current Assets / Total Current Liabilities
MBX Biosciences, Inc. (MBX) had Current Ratio of 24.19 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-61.92M |
|
-- |
|
-- |
|
$68.19M |
|
$-68.19M |
|
$6.27M |
|
$-61.92M |
|
$-61.92M |
|
$-61.92M |
|
$-61.92M |
|
$-61.92M |
|
$-61.92M |
|
$-68.19M |
|
$-67.95M |
|
10.64M |
|
10.64M |
|
$-5.82 |
|
$-5.82 |
|
| Balance Sheet Financials | |
$267.29M |
|
$1.08M |
|
$1.25M |
|
$268.54M |
|
$11.05M |
|
-- |
|
$0.04M |
|
$11.09M |
|
$257.44M |
|
$257.44M |
|
$257.44M |
|
33.42M |
|
| Cash Flow Statement Financials | |
$-54.68M |
|
$-160.59M |
|
$234.10M |
|
$30.52M |
|
$49.35M |
|
$18.83M |
|
$5.22M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
|
Current Ratio |
24.19 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-55.55M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-24.05% |
|
-24.05% |
|
-23.06% |
|
-24.05% |
|
$7.70 |
|
$-5.22 |
|
$-5.14 |
|